China Pharma Stock (NYSEAMERICAN:CPHI)


$ 0.53
Today's Range
$0.52 - $0.54
52-Week Range
$0.37 - $1.63
Market Cap

About China Pharma (NYSEAMERICAN:CPHI)

(NYSEAMERICAN:CPHI) China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products primarily to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. Its products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate and Ozagrel Sodium to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Bumetanide to treat edema diseases; and Candesartan for hypertension. It also provides Roxithromycin dispersible tablets for pharyngitis and tonsillitis; Cefaclor dispersible tablets for tympanitis, lower respiratory tract infection, urinary tract infections, and skin/skin tissue infection; Cefalexin capsules for acute tonsillitis; Anhydroandrographolide for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Clarithromycin granules and capsules; and Naproxen Sodium and PseudophedrineHydrochlorida sustained release tablets. In addition, the company offers Hepatocyte growth-promoting factor, Tiopronin, Compound Ammonium Glycyrrhetate S, and Omeparzole for the treatment of digestive diseases. Further, it provides Vitamin B6 injection; and Granisetron Hydrochloride injection to treat nausea and vomiting caused by radiotherapy and chemotherapy during the treatment of malignant tumors. The company offers its products through distributors, as well as through its network of 16 sales offices and approximately 1,000 sales representatives. China Pharma Holdings, Inc. is headquartered in Haikou, the People's Republic of China.
Show more

CPHI Stock Price

Statistics Highlights (NYSEAMERICAN:CPHI)

Shares Outstanding 43.58M Beta 0.20
Public Float 20.46M P/E Ratio -
% Short of Float 0.01% Dividend (Yield) -
Held by Insiders 53.06% Ex-Dividend Date
Held by Institutions 2.60% IPO Date Apr 17, 2002

CPHI Financial Summary

Dec 20 Dec 19 Dec 18
Revenue $10.87M $10.92M $12.33M
EBITDA $216.36K $-460.78K $-7.15M
Net Income $-2.87M $-20.70M $-10.75M
Total Assets $21.12M $22.24M $45.38M
Total Cash $957.65K $1.07M $1.19M
Total Debt $7.43M $4.50M $7.82M
Jun 21 Mar 21 Dec 20
Revenue $2.42M $2.36M $2.93M
EBITDA $-56.65K $-4.10K $-327.52K
Net Income $-824.76K $-767.33K $-1.21M
Total Assets $19.94M $19.85M $21.12M
Total Cash $1.75M $534.53K $957.65K
Total Debt $8.01M $7.22M $7.43M

CPHI Stock Price History

China Pharma Annual Stock Price History

Year Open Close Change
2021 $0.47 $0.53 12.60%
2021 $0.48 $0.47 -1.67%
2020 $0.23 $0.48 107.83%

China Pharma Daily Stock Price History

Date Open High Low Close Change Volume
Jun 27, 2022 $0.22 $0.24 $0.22 $0.22 -10.17% 165.90K
Jun 8, 2022 $0.23 $0.25 $0.23 $0.24 2.04% 146.63K
Jun 14, 2022 $0.25 $0.25 $0.24 $0.24 0.25% 127.12K


What is today's stock price of China Pharma (NYSEAMERICAN:CPHI)?

  • The current stock price of China Pharma (NYSEAMERICAN:CPHI) is $0.53.
  • Today CPHI stock price opened at $0.54 after previous close of $0.54.
  • During the day, China Pharma stock quote has varied from a low of $0.52 to a high of $0.54.

What is China Pharma's 52-week change?

  • CPHI 52-week high stock quote is $1.63, which is 208.00% above the current share price.
  • The China Pharma (NYSEAMERICAN:CPHI) 52-week low stock price is $0.37, which is 30.10% below the current share price.
  • China Pharma share price volatility (52-week beta) is 0.20.


How Much is China pharma Worth?

China pharma's worth today based on market capitalisation is $23.63M

How much dividend does China pharma Pay?

The current annualized dividend payout for CPHI stock is $0.00, the dividend yield is 0.00% and the payout ratio is 0.00%.
View More Details on China pharma's "Dividend" Section

What is China pharma’s Price to Earning (PE) ratio?

CPHI stock also has a Price to Sales (P/S) ratio of 2.34, a Price to Book of 3.41 and Price/Earnings to Growth (PEG) of 0.00.

What is the China pharma's ticker?

China pharma trades on the NYSE American stock market in USA under the ticker symbol "CPHI". China pharma’s stock symbol can also be displayed as "NYSEAMERICAN:CPHI".

When did CPHI go public?

China pharma completed its initial public offering (IPO) on April 17 ,2002.

Who are the owners of China pharma?

China pharma (NYSEAMERICAN:CPHI) is owned by 2.60% institutional shareholders and by 53.06% insiders. The rest is owned by the public.
Explore More Details on China pharma's “Ownership” Section

Who are the key executives of China pharma (CPHI)?

China pharma's key executive team includes the following managers:

  • Ms. Zhilin Li, Pres, CEO, Chairman & Interim CFO (1953)
  • Sam Hsing, Corp. VP (NA)
  • Ms. Diana Huang, BOD Sec. & IRO (NA)

What is China pharma’s Sector & Industry Classification?

China pharma (NYSEAMERICAN:CPHI) is classified under the "Healthcare" sector and under the "Drug Manufacturers-Specialty & Generic" industry.

How many employees work for China pharma?

Currently the number of employees working for China pharma is 237.

Where are China pharma's Headquarters?

China pharma (NYSEAMERICAN:CPHI) is headquartered in China.

What are China pharma's Address and Phone Number?

China pharma’s mailing address is No. 17, Jinpan Road, Haikou, China, 570216.
The company’s phone number is 86 89 8668 11730.

What is the official website for China pharma?

China pharma’s official website is